Alltech partners with ProGnosis Biotech to strengthen mycotoxin analysis

GLOBAL – Alltech, a global animal nutrition and biotechnology company, has formed an alliance with ProGnosis Biotech to strengthen mycotoxin testing, data analysis and risk-management capabilities across the feed and livestock value chain.

The collaboration will integrate ProGnosis Biotech’s rapid lateral flow test strips and readers with Alltech’s RAPIREAD platform, enabling users to interpret test results and access insights into mycotoxin trends and potential risks.

The partnership aims to help feed manufacturers and livestock producers make more informed decisions as mycotoxin threats become increasingly influenced by changing weather patterns.

Drought, heat stress and excessive rainfall can affect crop quality and create conditions that favour mycotoxin development.

Although the alliance has a global scope, Europe, the Middle East and Africa (EMEA) will be the primary focus of its initial phase.

The companies said the region presents growing mycotoxin challenges and an opportunity to combine their respective testing and risk-management capabilities.

“Alltech RAPIREAD allows users to understand their true mycotoxin risk as it relates to animal performance and health,” said Dr Alexandra Weaver, global technical support at Alltech.

“The collaboration between Alltech and ProGnosis gives those in the agricultural industry the ability to not only test for mycotoxins but also gain insights about their data.”

Combining rapid testing with risk analysis

ProGnosis Biotech develops rapid testing solutions to monitor contaminants and support food safety across supply chains.

Its lateral flow test strips and readers will provide the testing component of the integrated system, while RAPIREAD will support automated trend analysis and risk interpretation.

“Integrating ProGnosis Biotech’s rapid lateral flow test strips into Alltech’s RAPIREAD platform seamlessly fuses ProGnosis’ readers with Alltech’s global risk-management platform, combining rapid testing with automated trend and risk analysis,” said Sebastien Poisson, business development manager at ProGnosis Biotech.

The companies expect the combined capabilities to give users a clearer understanding of mycotoxin exposure and its potential implications for animal health and performance, supporting decisions on feed quality and risk management.

Sign up HERE to receive our email newsletters with the latest news updates and insights from Africa and the World, and follow us on our WhatsApp channel for updates.